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54 Poster Session-ITaste disorders are rarely discussed in the literature, it’s a significant
and prevalent problem reported by HSCT patients. The etiology of
taste disorders is multifactorial, however, the understanding of this
complain in this special group of patient should be better investi-
gated. The aim of this study was to evaluate prospectively, taste per-
ception, salivary flow rate and oral conditions in three different
groups of 61 adults patients submitted to allogeneic myeloablative
and non-myeloablative HSCT considering post-transplant timing.
Patients were classified into Group I(n5 20), up to 150 days, Group
II(n 5 20), between 151–1094 days, and Group III(n 5 21), above
1094 days. Taste acuity was measured by the taste thresholds for
the four basic tastes using 5ml of 4 solutions, in 3 concentration-
s(mol/L): NaCl(0.01;0.50;1.00), sucrose(0.01;0.50;1.00), citric
acid(0.32;0.0158;0.032), caffeine(1.988  10-5;0.644  10-2;1.277
 10–2). Patients considered flavors and their intensity as high,
medium and low. Unstimulated saliva was collected into separate
pre-weight plastic test glass and salivary flow rates were determinate
in ml/m. Oral cavity was examined in order to verify the presence of
GVHD, the presence of pain and oral infections. From those 61
patients, 31 presented cGVHD(Group I 5 3; Group II 5 14 and
Group III 5 14). In general, the sour and bitter perception was
not different between the 3 groups. The intensity of the sweet solu-
tion in the high and low concentrations were a challenging to be de-
termined for those patients(p5 0.04 and p5 0.05 respectively). For
the medium salty concentration and high sucrose concentration the
tastes were difficult to be determined only by the Group I(p 5 0.08
and p5 0.07 respectively). The saliva flow rate was diminished in 10/
61 patients in all periods(1.36 (0.01–1.3 5- SD 0.296) and hyposali-
vation was more intense in the Groups II/III(p5 0.007). There was
no correlation of taste dysfunction with oral cGVHD lesions. The
results indicate that, despite the hyposalivation, taste alterations
were only observed for the sweet and salty tastes even in patients
up to 3 years post-HSCT. These results may indicate that taste alter-
ations post-HSCT are not correlated to oral cGVHD and to hypo-
salivation but may be considered as an individual response of the
HSCT.142
RELATIVE IMPACT OF PSYCHOSOCIAL FACTORS, COMORBIDITIES, AND
DISEASE RISK ON THE UTILIZATION OF RESOURCES AND OVERALL
OUTCOME IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL
TRANSPLANTATION
Speckhart, D.S.1, Holland, H.K.1,2, Solomon, S.R.1,2, Bashey, A.1,2,
Morris, L.E.1,2, Kerns, L.1, Berry, T.1 1The Blood and Marrow Trans-
plant Program at Northside Hospital, Atlanta, GA; 2The Blood and
Marrow Transplant Group of Georgia, Atlanta, GA
Several studies have begun to examine the relationship between
psychosocial variables and outcome in hematopoietic stem cell trans-
plantation (HSCT). Previous studies have also looked at the rela-
tionship between the Hematopoietic Cell Transplantation
Comorbidity Index (HCT-CI) and overall survival in HSCT which
demonstrated a negative relationship between HCT-CI and overall
survival. In this study, data was collected on 128 patients undergoing
HSCT. Based on the patient’s TERS score, each patient was strati-
fied into one of two groups (low/moderate risk (n5 96) vs. high risk
(n 5 32)) based on their predicted psychosocial risk for problems
during transplant. Patients were also stratified into two categories
on the HCT-CI (low (n5 102) vs. high (n5 26)) based on the num-
ber of comorbid features present pre-transplant. Patients were also
grouped into disease risk categories as classified by the CIBMTR
criteria. Only the TERS was found to be a significant predictor of
utilization of resources (length of hospitalization) between low/mod-
erate risk (26 days) versus high risk (40 days) patients (p\.02). The
HCT-CI (p 5 .014) and CIBMTR disease risk status (p 5 .02)
were found to be significantly correlated with overall survival. Alone,
the TERS showed a similar trend but did not appear to have a signif-
icant impact on overall survival. Those patients who scored lowest on
all three measures (TERS, HCT-CI and CIBMTR disease risk) had
the best overall survival rate, nearing 75% survival at 2 years post
HSCT. One would conclude that although psychosocial factors im-
pact the utilization of resources, well equipped transplant centers can
provide a relatively safe method for high risk psychosocial patients to
undergo HSCT. These results reinforce the impact of the HCT-CIand disease risk on transplant outcome previously found at other
large transplant centers.143
SOLID ORGAN TRANSPLANTATION IN SURVIVORS OF HEMATOPOIETIC
CELL TRANSPLANTATION: A SINGLE INSTITUTION CASE SERIES
Beitinjaneh, A., Burns, L., Majhail, N. University of Minnesota,
Mineapolis, MN
Advancements in the field of hematopoietic cell transplantation
(HCT) has led to an increasing number of long-term HCT survi-
vors. For selected survivors with severe organ dysfunction, solid or-
gan transplantation (SOT) may offer the best chance for better
quality of life and extended survival. However, SOT following
HCT has not been well described. We report a single institution
experience of SOT in 11 HCT recipients. Transplanted organs
included kidney (N 5 7), lung (N 5 2), liver (N 5 2) and heart
(N 5 1). Age at HCT ranged from 2 to 59 years. All patients were
100% donor engrafted and in complete remission from their under-
lying malignancy at the time of SOT. Among recipients of allogeneic
HCT, 5/9 had a history of chronic graft-versus-host disease
(GVHD); only three patients had active GVHD at the time of
SOT. Median time between HCT and SOT was 7.4 years (range
1.2–15.9 years). Four patients have died, one patient received his
SOT at another institution and was lost for followup, while six
patients are alive with a median followup of 2 years (range 0.5 – 6
years). Among the 10 patients with post-SOT followup information,
9 had normal function of the transplanted solid organ at the time of
last contact or death. Two patients developed cytomegalovirus reac-
tivation, one patient developed post transplantation lymphoprolifer-
ative disorder, and one patient developed second malignancy after
SOT. SOT is feasible in selected HCT recipients with organ failure
and is associated with favorable long-term survival and graft func-
tion. More research is needed to further delineate the subset of
HCT survivors who will benefit the most with SOT with the least
risk of significant complications.
Patients’ characteristics and outcome
Patient Organ & Time b/w Follow-upage/sex HCT type Diagnosis Indication HCT & SOT after SOT27 F Autologous Hodgkin’s
lymphomaLung,
Interstitial
fibrosis7.4 yrs 2 yrs, alive56 M Autologous Myeloma Cadaveric
kidney,
ESRD2.9 yrs 2 yrs, alive37 M Allo Sib Aplastic
anemiaSibling
kidney,
ESRD5.6 yrs 8.9 yrs,
dead
(ischemic
cardiomyopathy)46 M Allo Sib Mantle
cell
lymphomaSibling
kidney,
ESRD7.4 yrs 2.2 yrs, dead
(metastatic
squamous
cell cancer
of tongue)59 M Allo Sib CML Sibling
kidney,
ESRD15.9 yrs 5.9 yrs, alive41 M Allo MUD CML Combined
heart and
cadaveric kidney,
Cardiomyopathy
and ESRD12.3 yrs 0.5 yrs, alive2 F Allo Sib Neurob
lastomaSibling kidney,
ESRD9.3 yrs 6 yrs, alive8 F Allo Sib AML Cadaveric liver,
HCV cirrhosis6.5 yrs 1 mo, dead
(aspergillosis)12 M Allo Sib Aplastic
anemiaCadaveric liver,
fulminant
hepatitis9.8 yrs 1.5 yrs, alive(Continued )
Poster Session-I 55. (Continued )Patient
age/sex HCT type DiagnosisOrgan &
IndicationTime b/w
HCT & SOTFollow-up
after SOT16 F Allo MUD CML Lung,
Bronchiolitis
obliterans1.2 yrs 1 mo, dead
(multi-organ
failure)17 M Allo MUD ALL Kidney, ESRD 6.2 yrs Lost to
followupAllo sib – matched sibling donor; MUD – matched unrelated donor; CML – chronic
myeloid leukemia; AML – acute myeloid leukemia; ALL – acute lymphoblastic leukemia;
ESRD – end stage renal disease; HCV – hepatitis C144
A STUDY ON THE SEXUAL DYSFUNCTION OF FEMALE RECIPIENTS WHO
UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION
Kim, J.W., Kim, K.S., Bok, J.N., Lee, S.Y. The Catholic University of
Korea, Seoul, Korea
Background/ Aims: Many studies have shown sexual dysfunction
in recipients who underwent HSCT, particularly for female recipi-
ents. However, there were no studies for sexual dysfunction of female
recipients who underwent HSCT in Korea, because the sexual prob-
lem was just considered very private. The purposes of this study was
to analysis the level of sexual dysfunction of female recipients who
underwent HSCT and provide basic data contributed in taking
care of female recipients having sexual problems after HSCT.
Methods: The sexual function of 60 female recipients who have
been visiting hospital after HSCT, were selected from database of
Catholic HSCT center, St. Mary’s Hospital; was assessed using the
Korean translated version of FSFI (female sexual function index)
questionnaire.
Results: More than 80% of female recipients had hematological
malignancies; more than 76.7 % were allograft recipients. Gonadal
disturbances were present in 51.7 % of female recipients. 22.5 %
of them were receiving estrogen replacement and only 23.3% had
regular menses. 61.7 % of them had never done sexual activity in
the past four weeks from the assessment date. The reason why they
didn’t have sexual activity was associate with the uninteresting of
themselves (48.3%), the fear of infection (44.9%) and the uninterest-
ing of their sexual partner (13.8%). More than 94% of female recip-
ients were found to have low level of FSFI total score as sexual
dysfunction. They were found to have each domain scores on sexual
desire, arousal, lubrication, orgasm and satisfaction as sexual dys-
function; 80.8%, 98.1%, 92.3%, 86.5%, 84.6% and 86.5%
of them respectively. These results showed significant sexual
dysfunction of female recipients who underwent HSCT.
Conclusion: The Sexual dysfunction of female recipients, who
underwent Hematopoietic Stem Cell Transplantation, is usual after
HSCT. We suggest stressing the importance of intervention for fe-
male recipients having sexual problems and there are needed to apply
hormonal, mechanical, and behavioral methods to prevent sexual
dysfunction in further studies.145
SUICIDE IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTA-
TION (HSCT) PATIENTS, IS IT A PROBLEM?
Larsen, H.B.1, Petersen, H.1, Roepstorff, C.1, Sengelow, H.1,
Heilmann, C.2 1Rigshospitalet, Copenhagen, Denmark; 2Rigshospitalet,
Copenhagen, Denmark
Introduction: A review of the literature showed that the prob-
lem of suicide and suicide attempts among HSCT patients has
only been examined in two studies from the 1990´ties.
Since suicide continues to be a problem in HSCT patients we
wanted to examine the problem in a Danish population based
context.
Patients andmethods:Follow-up data from the Danish cohort of
HSCT patients (N: 1217 September 1. 2008) revealed that three pa-
tients had committed suicide, and that at least three patients had
attempted to do so.Results: The three patients who committed suicide were all
males, two of them were severely ill, one with a prolonged inpatient
period due to transplantation complications and one had recently
been diagnosed with relapse following HSCT. The last patient
was 10 years from HSCT and suffered from depression. Whether,
in the Danish cohort, other patients have committed suicide may be
a matter of definition e.g. a patient, who refused to take his medi-
cine, because he did not wish to live, die three months later due
to GvHD. The three patients whom we know attempted suicide
are all females, and their attempts occurred approximately 10 years
after HSCT, during childhood or adolescence. One patient has se-
vere extensive long-term complications following HSCT and the
other two patients have been complaining of depressive thoughts.
Whether other patients have attempted suicide is unknown, but it
is likely that our follow-up data collection does not always pick
up such events.
Conclusion: Suicide and suicide attempts are not well described
in the HSCT literature. It’s unknown whether we actually capture
all suicides and suicide attempts in our medical records and by our
data collection procedures. It’s also unknown what the incidence
of suicide is following treatment with HSCT. We would therefore
suggest a multicenter/registry analysis of the problem. In order to
capture information regarding HSCT patients that commit suicide
we need to know their age, gender, time after HSCT, complications
(e.g. GvH, infection) and psychological profile. This would provide
us with further knowledge and understanding of the problem, and
hopefully help us care better for patients at risk for post transplanta-
tion suicide.146
PANCREATIC ATROPHY IS ASSOCIATED WITH GASTROINTESTINAL
CHRONIC GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Nakasone, H.1,2, Ito, A.1, Endo, H.1, Muramatsu-Kida, M.1, Izutsu, K.1,
Usuki, K.1 1Kanto Medical Center, NTT, EC; 2Saitama Medical Center,
Jichi Medical University Graduate School
The weight loss and malnutrition commonly observed in patients
following hematopoietic stem cell transplantation is due to pancre-
atic insufficiency, at least in part. To date, few reports have evaluated
pancreatic morphology in the chronic phase of transplantation. We
evaluated pancreatic atrophy following allogeneic peripheral blood
stem cell transplantation (PBSCT) by retrospectively reviewing pa-
tients with chronic graft-versus-host disease (cGVHD) following
PBSCT from related donors. The study was carried out at our insti-
tution between June 2001 and October 2007. Computed tomogra-
phy (CT) scans were available for pre- and post-transplantation
pancreatic assessment from 25 of 26 patients with cGVHD who
had survived at least 100 days. The median patient age was 60 years.
Sixteen patients received fludarabine-based reduced-intensity condi-
tioning regimens. The median duration of observation for survivors
was 4.1 years. Pancreatic atrophy was observed in five (20%) of 25
patients, while steatorrhea was documented in only one (5%). Uni-
variable analysis revealed that pancreatic atrophy was significantly
associated with involvement of liver (P5 0.041) and gastrointestinal
(GI) tract (P 5 0.022) of cGVHD, while multivariable analysis
showed that only GI cGVHD was a significantly associated factor
[OR: 16.0 (95%CI: 1.1–364), P 5 0.043]. Overall survival (OS) be-
tween patients with and without pancreatic atrophy was similar
(40.0% and 56.3%, respectively; P 5 0.98). Morphological assess-
ment by CT detected pancreatic abnormalities more sensitively, eas-
ily, and less invasively than assessment via steatorrhea observation or
biopsy. Pancreatic atrophy is not a rare complication of PBSCT in
patients with cGVHD, particularly in those with GI cGVHD.147
PSYCHOSOCIAL FACTORS AND OVERALL SURVIVAL AFTER AUTOLOGOUS
AND ALLOGENEIC BMT
Hahn, T.1, Jensen, S.1, Lopez, F.1, Zevon, M.1, Tan, W.2, Wilding, G.2,
Paddon, C.1, White, J.1, Thomas, J.1, Battiwalla, M.1, Smiley, S.L.1,
McCarthy, P.L.1 1Roswell Park Cancer Institute, Buffalo, NY; 2Roswell
Park Cancer Institute, Buffalo, NY
Various psychosocial factors have been assessed in BMT patients
(pts), but there are few reports of a comprehensive psychosocial
